Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment

NCT01100125 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: sitagliptin
DRUG: insulin dose increase

Sponsor

Seoul National University Bundang Hospital